Pediatric Endocrine Society https://validator.w3.org/feed/docs/rss2.html Home Long-Acting Growth Hormone Table March 2026 President’s Letter New Drugs and Therapeutics Update: Sogroya® (somapacitan-beco) Injection Depo-Provera® and Increased Risk of Meningioma: FDA-Label Update Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics PES Annual Meeting PES Travel Grants Health Systems Disparity Initiative PedsENDO365 Society History In Memoriam: Delbert A Fisher, MD (August 12, 1928 – March 4, 2026) PES Ethics SIG Webinar: Ethics Case-Based Discussion – Spring Edition PES SIG State of the Art Series PES Education Committee Webinar Series 2026 Annual Meeting Exhibitors and Sponsors March Historical Tidbit – Then and Now: This Month in Endocrine History  March Fellow Spotlight – Sahaj Singh, MD  New Meds and Tech: DESMODA™ (desmopressin acetate) Oral Solution  Industry Sponsored Symposia Find a Pediatric Endocrinologist PES Hypoglycemia SIG Webinar: Diagnosis and Management of Ketotic Hypoglycemia Advanced Practice Providers (APP) February APP Spotlight – Karen L. Clark, MMSc, PA‑C 2026 PES Annual Meeting Poster Presenters Resource Page PES TREND SIG & PedsEndo 365 Webinar: Evaluation and Management of Tumor Related Endocrine and Neuroendocrine Disorders PedsENDO Discovery Program PES Membership PES Research Surveys Research Affairs Committee February Fellow Spotlight – Rachael Mullin, DO, MS   Specific Aims Initiative PES Hypoglycemia SIG Meeting February 2026 President’s Letter Jessica Widing Clinical Studies Drug alerts and recalls – Depo-Provera and Increased Risk of Meningioma: FDA-Label Update New Meds and Tech: Mounjaro (tirzepatide) approved in Pediatrics  Online Education Professional Links 2026 Open Fellowship Positions Future Meetings Sonja Hix Ryan Gorham Jason B. Fluke Maureen Thompson Online Community Amanda Joslin Leadership SEED